DENEPO LLC Announces FDA InvisiScar(R) Registration

Top Quote Our mission statement is "To supply the market with a low-cost means to non-surgically reduce the appearance of scars resulting from surgery, burns, piercing, cystic acne and cuts at a very reasonable price". End Quote
  • (1888PressRelease) March 20, 2012 - Cumming, Georgia - DENEPO LLC. (The "Company") is pleased to announce it has registered the InvisiScar® brand name with the FDA in compliance with registration regulations.

    Clinical studies have shown using topical SILASTIC Gel Sheeting the overall the success rate (somewhat improved to greatly improved) for the treatment of hypertrophic and keloid scars is high (95%).

    A copy of the FDA record can be found on the website link below, showing the Company (FDA registration owner number 3007700381 and owner operator number 10029575) can sell under the InvisiScar® product name.

    The Company is confident its scar treatment product line is of equal, or better, quality to the major companies in this marketplace while having the added feature of being applied by either hypoallergenic tape or self-adhesive product at a comparable price.

    The Company website is

  • FB Icon Twitter Icon In-Icon
Contact Information